Radiotherapy of Multiple Brain Metastases Using AGuIX®

PHASE2UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

June 26, 2024

Study Completion Date

March 26, 2025

Conditions
Brain Metastases, AdultRadiotherapy
Interventions
DRUG

AGuIX®

"3 intravenous injection at 100mg/kg~* D0: AGuIX® injection followed by MRI (within 7 days before commencement of WBRT)~* Fr1: AGuIX® injection before the first radiation session~* Fr6: AGuIX® injection before the sixth radiation session"

RADIATION

Whole Brain Radiation Therapy

30 Gy in 10 fractions of 3 Gy over 2-3 weeks

Trial Locations (14)

14000

Crlcc Francois Baclesse, Caen

21079

Centre Georges François Leclerc, Dijon

31059

Institut Claudius Regaud Institut Universitaire du Cancer Toulouse Oncopole Radiothérapie, Toulouse

33000

CRLCC - Institut Bergonié, Bordeaux

34298

Institut Régional du Cancer, Montpellier

38700

Centre Hospitalier Universitaire Grenoble-Alpes, Grenoble

54519

Institut de Cancérologie de Lorraine ALEXIS VAUTRIN, Vandœuvre-lès-Nancy

67085

Crlcc Paul Strauss, Strasbourg

69373

Centre Leon Berard Lyon, Lyon

69495

Hospices Civils de Lyon-Hôpital Lyon Sud, Lyon

74374

Centre Hospitalier Annecy Genevois, Annecy

75015

Hôpital Européen Georges Pompidou, Paris

75651

La Pitié Salpêtrière - Charles Foix, Paris

92210

Institut Curie Saint Cloud, Saint-Cloud

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NH TherAguix SAS

OTHER

lead

University Hospital, Grenoble

OTHER